Covered recipient · General Payments record
HILA AZULAY
Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease
General Payments · PY2018–2024
$1,250.96
- Reported across 21 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $416.92 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $179.03 | 5 |
| Bayer HealthCare Pharmaceuticals Inc. | $113.71 | 1 |
| United Therapeutics Corporation | $105.75 | 1 |
| Merck Sharp & Dohme Corporation | $18.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $4.77 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078868318 | CMS |
| Actelion Pharmaceuticals US, Inc. | $27.29 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078868066 | CMS |
| Actelion Pharmaceuticals US, Inc. | $105.68 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078868150 | CMS |
| Actelion Pharmaceuticals US, Inc. | $19.71 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078868094 | CMS |
| Actelion Pharmaceuticals US, Inc. | $21.58 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078868112 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $113.71 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086268487 | CMS |
| Merck Sharp & Dohme LLC | $18.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141729276 | CMS |
| United Therapeutics Corporation | $105.75 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149448486 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.